(Q55137362)

22 June 2018

title

Increased expression of trk proto-oncogene by gamma-interferon in human neuroblastoma cell lines. (English)

1 reference

22 June 2018

1 reference

A Shikata

1

1 reference

22 June 2018

T Sugimoto

2

1 reference

22 June 2018

H Hosoi

3

1 reference

22 June 2018

Y Sotozono

4

1 reference

22 June 2018

T Shikata

5

1 reference

22 June 2018

T Sawada

6

1 reference

22 June 2018

L F Parada

7

1 reference

22 June 2018

publication date

1 February 1994

1 reference

22 June 2018

number of pages

5

1 reference

Japanese Journal of Cancer Research

inferred from page(s)

published in

1 reference

22 June 2018

volume

85

1 reference

22 June 2018

issue

2

1 reference

22 June 2018

page(s)

122-126

1 reference

22 June 2018

Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919423

Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas

24 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919423

Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour

24 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919423

Determination of cell surface membrane antigens common to both human neuroblastoma and leukemia-lymphoma cell lines by a panel of 38 monoclonal antibodies.

24 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919423

Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma

24 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919423

Construction of a modular dihydrofolate reductase cDNA gene: analysis of signals utilized for efficient expression

24 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919423

Identical expression of cell surface membrane antigens on two parent and eighteen cloned cell lines derived from two different neuroblastoma metastases of the same patient.

24 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919423

Neuritic growth from a new subline of PC12 pheochromocytoma cells: cyclic AMP mimics the action of nerve growth factor

24 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919423

In vitro antigenic modulation of human neuroblastoma cells induced by IFN-gamma, retinoic acid and dibutyryl cyclic AMP.

24 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919423

Differential expression of N-myc and c-src proto-oncogenes during neuronal and schwannian differentiation of human neuroblastoma cells

24 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919423

Effect of human interferons on morphological differentiation and suppression of N-myc gene expression in human neuroblastoma cells

24 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919423

Multiple defects of the nerve growth factor receptor in human neuroblastomas.

24 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919423

Interferon-gamma modulates terminal differentiation and the expression of desquamin in cultured keratinocytes

24 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919423

Increased epidermal growth factor receptor gene expression by gamma-interferon in a human breast carcinoma cell line

24 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919423

The trk Proto-Oncogene Product: a Signal Transducing Receptor for Nerve Growth Factor

24 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919423

The rat trk protooncogene product exhibits properties characteristic of the slow nerve growth factor receptor

24 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919423

Cell surface membrane antigen present on neuroblastoma cells but not fetal neuroblasts recognized by a monoclonal antibody (KP-NAC8).

24 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919423

Differential susceptibility of HLA class II antigens induced by gamma-interferon in human neuroblastoma cell lines

13 August 2018

1 reference

12 December 2020

Number and organization of actin-related sequences in the mouse genome

1 reference

12 December 2020

Expression and function of the nerve growth factor receptor (TRK-A) in human neuroblastoma cell lines

1 reference

12 December 2020

Neuroblastoma: inverse relationship between expression of N-myc and NGF-r

1 reference

12 December 2020

Inverse relationship between trk expression and N-myc amplification in human neuroblastomas

1 reference

12 December 2020

Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis

1 reference

12 December 2020

10.1111/J.1349-7006.1994.TB02070.X

Identifiers

DOI

1 reference

22 June 2018

PMC publication ID

5919423

1 reference

22 June 2018

PubMed publication ID

8144393

1 reference

22 June 2018